Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic Geriatric Assessment (pGA) Before Bispecific Antibody and CAR-T-Cell Therapy (GA-ACT Trial) for the Prediction of Toxicity and Outcomes in Older Patients Scheduled for Chimeric Antigen Receptor T-Cell Therapy (CAR-T-Cell-Therapy) or Bispecific Antibody (bsAB) Treatment

NCT07309497 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT07309497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07309497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic Geriatric Assessment (pGA) Before Bispecific Antibody and CAR-T-Cell Therapy (GA-ACT Trial) for the Prediction of Toxicity and Outcomes in Older Patients Scheduled for Chimeric Antigen Receptor T-Cell Therapy (CAR-T-Cell-Therapy) or Bispecific Antibody (bsAB) Treatment
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Recruiting
Start date
December 12, 2025
Completion date
February 1, 2028
Enrollment
208 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bispecific antibody, cart therapy, geriatric hematology, multiple myeloma (mm), lymphoma, large b-cell, diffuse (dlbcl), lymphoma